» Articles » PMID: 38659036

Evaluation of Different Genomic Regions of Rotavirus B and Rotavirus C for Development of Real-time RT‒PCR Assays

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2024 Apr 24
PMID 38659036
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The causative agents of diarrhea, rotavirus B (RVB) and rotavirus C (RVC) are common in adults and patients of all age groups, respectively. Due to the Rotavirus A (RVA) vaccination program, a significant decrease in the number of gastroenteritis cases has been observed globally. The replacement of RVA infections with RVB, RVC, or other related serogroups is suspected due to the possibility of reducing natural selective constraints due to RVA infections. The data available on RVB and RVC incidence are scant due to the lack of cheap and rapid commercial diagnostic assays and the focus on RVA infections. The present study aimed to develop real-time RT‒PCR assays using the data from all genomic RNA segments of human RVB and RVC strains available in the Gene Bank.

Results: Among the 11 gene segments, NSP3 and NSP5 of RVB and the VP6 gene of RVC were found to be suitable for real-time RT‒PCR (qRT‒PCR) assays. Fecal specimens collected from diarrheal patients were tested simultaneously for the presence of RVB (n = 192) and RVC (n = 188) using the respective conventional RT‒PCR and newly developed qRT‒PCR assays. All RVB- and RVC-positive specimens were reactive in their respective qRT‒PCR assays and had Ct values ranging between 23.69 and 41.97 and 11.49 and 36.05, respectively. All known positive and negative specimens for other viral agents were nonreactive, and comparative analysis showed 100% concordance with conventional RT‒PCR assays.

Conclusions: The suitability of the NSP5 gene of RVB and the VP6 gene of RVC was verified via qRT‒PCR assays, which showed 100% sensitivity and specificity. The rapid qRT‒PCR assays developed will be useful diagnostic tools, especially during diarrheal outbreaks for testing non-RVA rotaviral agents and reducing the unnecessary use of antibiotics.

References
1.
Kang G, Arora R, Chitambar S, Deshpande J, Gupte M, Kulkarni M . Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis. 2009; 200 Suppl 1:S147-53. DOI: 10.1086/605031. View

2.
Malik Y, Chandrashekar K, Sharma K, Prasad M, Prasad G . Evidence for Occurrence of Human group B rotavirus in Central India Based on Characterization of NSP2 Gene. Indian J Virol. 2013; 22(2):98-103. PMC: 3550739. DOI: 10.1007/s13337-011-0046-z. View

3.
Joshi M, Jare V, Gopalkrishna V . Group C rotavirus infection in patients with acute gastroenteritis in outbreaks in western India between 2006 and 2014. Epidemiol Infect. 2016; 145(2):310-315. PMC: 9507622. DOI: 10.1017/S0950268816002363. View

4.
Mori K, Hayashi Y, Akiba T, Nagano M, Tanaka T, Hosaka M . Multiplex real-time PCR assays for the detection of group C rotavirus, astrovirus, and Subgenus F adenovirus in stool specimens. J Virol Methods. 2012; 191(2):141-7. DOI: 10.1016/j.jviromet.2012.10.019. View

5.
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S . MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013; 30(12):2725-9. PMC: 3840312. DOI: 10.1093/molbev/mst197. View